Quent Capital’s Genmab GMAB Stock Holding History

Quent Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22	Closed	-$1K	–	1339
2022 Q3	$1K	Hold	22	–	–	﹤0.01%	1155
2022 Q2	$1K	Sell	22 -25	-53%	-$810	﹤0.01%	1101
2022 Q1	$2K	Buy	47 +22	+88%	+$755	﹤0.01%	1146
2021 Q4	$1K	Buy	+25	New	+$1.04K	﹤0.01%	1032

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quent Capital's GMAB Position: Q4 2022 in Review

Quent Capital sold out of Genmab (GMAB) in Q4 2022, closing a stake of 22 shares — an estimated $1K sold.

Quent Capital first reported a position in GMAB in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q1 2022. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.

Quent Capital reported no remaining Genmab position as of Q4 2022 after selling out during the quarter.
Quent Capital sold 22 Genmab shares in Q4 2022, an estimated $1K.
Quent Capital first reported a position in Genmab in Q4 2021 and held it in 4 quarters.
Quent Capital's Genmab position peaked at $2K in Q1 2022.
237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.

Based on Quent Capital's 13F filing for Q4 2022, filed 19 Jan 2023.